Dana Klug
Research Investigator Arvinas, Inc.
Seminars
Tuesday 28th October 2025
From Occupancy to Elimination: Differential Biology of ARV-806 & Oral Pan-KRAS PROTAC Degradation
2:00 pm
Download the Full Event Guide for Full Session Details.
- Sharing ARV-806 preclinical pharmacology
- Highlighting first data showing oral pan-KRAS PROTAC anti-tumor activity
